- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/12 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 277/12
Total number of patents in this class: 28
10-year publication summary
|
2
|
3
|
1
|
1
|
1
|
0
|
4
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Florida Research Foundation, Inc. | 4173 |
7 |
| The University of Electro-Communications | 221 |
4 |
| Nacuity Pharmaceuticals, Inc. | 47 |
3 |
| FerroKin Biosciences, Inc. | 5 |
2 |
| The Regents of the University of California | 20720 |
1 |
| Janssen Pharmaceutica N.V. | 3171 |
1 |
| Kaneka Corporation | 4693 |
1 |
| Abbvie Inc. | 1836 |
1 |
| Campus Create Co., Ltd. | 3 |
1 |
| Universidad de Zaragoza | 186 |
1 |
| University of Copenhagen | 435 |
1 |
| University of Utah Research Foundation | 1860 |
1 |
| Consorcio Centro de Investigacion Biomedica en Red, M.p | 167 |
1 |
| Fundacion Instituto de Investigacion Sanitaria Aragon | 13 |
1 |
| Instituto Aragonés de Ciencias de La Salud | 14 |
1 |
| Kurogane Kasei Co., Ltd. | 6 |
1 |
| Other owners | 0 |